Literature DB >> 21142437

Effects of continuous intravenous infusion of MCI-186 on functional recovery after spinal cord injury in rats.

Souichi Ohta1, Yasushi Iwashita, Ryosuke Kakinoki, Takashi Noguchi, Takashi Nakamura.   

Abstract

We investigated the effects of a free radical scavenger, MCI-186 (edaravone), on neuroprotection in the rat post-traumatic spinal cord using various doses and routes of administration. The injury was produced with a weight-drop device. Lipid peroxide formation in the spinal cord was measured using the thiobarbituric acid test for malonyldialdehyde (MDA). In the first experiment, MDA production in the untreated post-traumatic spinal cord reached peak values at 1 h post-trauma, and gradually decreased to control levels in 7 days. In the second experiment, rats received twice-daily injections (0, 1, 3, 5, 10, or 20 mg/kg) for 3 days. We found that 3 mg/kg was most effective functionally and histologically. In the third experiment, rats received a 3 mg/kg bolus + continuous infusion (0, 1.5, 2.4, or 3.0 mg/kg/h) for 1, 2, 4, and 8 h. We found that a 3 mg/kg bolus + infusion of 3.0 mg/kg/h was most effective for the inhibition of MDA production. In the fourth experiment, a 3 mg/kg bolus given once immediately after injury and twice daily for 3 days, a 3 mg/kg bolus + 3.0 mg/kg/h for 1 day, or a 3 mg/kg bolus + 3.0 mg/kg/h for 3 days were administered. The continuous infusion for 1 day showed significant improvement functionally and histologically, but continuous infusion at the same rate for another 2 days did not show any further improvement. To effectively reduce secondary neuronal damage, strong inhibition of free radical chain reactions at the early stage, particularly within the first 24 h post-trauma, is important.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21142437     DOI: 10.1089/neu.2010.1477

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  4 in total

1.  Mn (III) tetrakis (4-benzoic acid) porphyrin protects against neuronal and glial oxidative stress and death after spinal cord injury.

Authors:  Lokanatha Valluru; Yao Diao; Jorge E Hachmeister; Danxia Liu
Journal:  CNS Neurol Disord Drug Targets       Date:  2012-09       Impact factor: 4.388

2.  Edaravone Modulates Neuronal GPX4/ACSL4/5-LOX to Promote Recovery After Spinal Cord Injury.

Authors:  Yilin Pang; Xinjie Liu; Xu Wang; Xuelian Shi; Lei Ma; Yan Zhang; Tiangang Zhou; Chenxi Zhao; Xu Zhang; Baoyou Fan; Jian Hao; Wenxiang Li; Xiaoqing Zhao; Rong Zhang; Songlin Zhou; Xiaohong Kong; Shiqing Feng; Xue Yao
Journal:  Front Cell Dev Biol       Date:  2022-05-18

3.  The Pathogenesis of Neurotrauma Indicates Targets for Neuroprotective Therapies.

Authors:  Jacek M Kwiecien
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

4.  Edaravone attenuates sustained pial arteriolar vasoconstriction independently of endothelial function after unclamping of the abdominal aorta in rabbits.

Authors:  Tomohiro Michino; Kumiko Tanabe; Motoyasu Takenaka; Shigeru Akamatsu; Masayoshi Uchida; Mami Iida; Hiroki Iida
Journal:  Korean J Anesthesiol       Date:  2021-06-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.